Impact of Technology on the Sleep Apnea Oral Appliances Market
The global market for Sleep
Apnea Oral Appliances is experiencing rapid growth. In 2023, this
market was valued at $0.4 billion. However, it is projected to reach $0.9
billion by 2028, expanding at an impressive compound annual growth rate (CAGR)
of 15.2% during the forecast period of 2023 to 2028.
A key driver fueling this market's expansion is the large
pool of undiagnosed sleep apnea patients worldwide. Sleep apnea, a common sleep
disorder affecting people across all age groups, is estimated to impact between
10% and 30% of adults in the United States alone, according to the American
Sleep Apnea Association. With changing lifestyles contributing to rising
obesity rates globally, the number of potential sleep apnea patients is likely
to surge, presenting significant growth opportunities for oral appliance
manufacturers.
Download a PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=105423877
While continuous positive airway pressure (CPAP) therapy
remains an effective treatment for obstructive sleep apnea (OSA), poor patient
compliance poses a challenge. Many patients struggle to adhere to the
recommended usage of CPAP machines, often using them for fewer than four hours
per night. This lack of adherence compromises the long-term health benefits of
CPAP therapy, creating an opportunity for oral appliances as an alternative
treatment option.
However, the sleep apnea oral appliances market also faces
some hurdles. One major challenge is the high cost associated with customizing
these devices to fit each patient's unique oral anatomy. This customization
process is time-intensive and limits the potential for mass production, making
customized oral appliances less accessible than standard CPAP treatment for
some patients.
The market is dominated by prominent players such as
SomnoMed (Australia), ResMed (US), Whole You, Inc. (US), ProSomnus Sleep
Technologies (US), and Vivos Therapeutic, Inc. (US). These companies are
well-established, financially stable manufacturers with diversified product
portfolios, state-of-the-art technologies, and strong global sales and
marketing networks.
In terms of product segments, mandibular advancement devices
are expected to dominate the market in 2022 due to their enhanced effectiveness
and patient comfort. Additionally, physician-prescribed or customized oral
appliances are anticipated to lead the market based on purchase type, as they
offer a more patient-centric approach with individualized treatment plans.
Geographically, North America is poised to dominate the
sleep apnea oral appliances market during the forecast period, driven by rising
obesity rates, ongoing technological advancements in sleep apnea devices, and
favorable regulatory and reimbursement scenarios.
With increasing awareness and diagnosis of sleep apnea, as
well as the availability and accessibility of oral appliances, the sleep apnea
oral appliances market is positioned for remarkable growth in the coming years.
Comments
Post a Comment